VIVO OPPORTUNITY, LLC sold 14.0% of their position (1.02M shares) of SOLENO THERAPEUTICS INC on the open market
Open‑market sale worth $49.21M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 8/29/2024ACC: 0001213900-24-074051
10% Owner
Since May 2023
-1.02M
Net shares
Net seller
$49.21M
Total sold
3
Open market trades
0B · 3S
3
Total transactions
1.02M disposed
Non-Derivative Transactions3
Common Stock
Indirect
Shares
−500K
Price / share
$48.73
Trade value
$24.36M
% of position
6.8%
8/27/2024
7.32M→6.82M
Common Stock
Indirect
Shares
−425K
Price / share
$47.35
Trade value
$20.12M
% of position
6.2%
8/28/2024
6.82M→6.39M
Common Stock
Indirect
Shares
−100K
Price / share
$47.22
Trade value
$4.72M
% of position
1.6%
8/29/2024
6.39M→6.29M
Total
Net shares
−1.02M
Net value
-$49.21M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 8/27/2024 | S · Sale | −500K | $48.73 | $24.36M | 6.8% | 7.32M | 6.82M |
| Common Stock Indirect | 8/28/2024 | S · Sale | −425K | $47.35 | $20.12M | 6.2% | 6.82M | 6.39M |
| Common Stock Indirect | 8/29/2024 | S · Sale | −100K | $47.22 | $4.72M | 1.6% | 6.39M | 6.29M |
| Total | −1.02M | -$49.21M | ||||||
Derivative Transactions0
No derivative transactions reported